|Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens|
ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ...
Journal of Clinical Oncology 26 (32), 5233, 2008
|Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade|
SG Downey, JA Klapper, FO Smith, JC Yang, RM Sherry, RE Royal, ...
Clinical Cancer Research 13 (22), 6681-6688, 2007
|High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the …|
JA Klapper, SG Downey, FO Smith, JC Yang, MS Hughes, US Kammula, ...
Cancer 113 (2), 293-301, 2008
|Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer|
N Zacharakis, H Chinnasamy, M Black, H Xu, YC Lu, Z Zheng, A Pasetto, ...
Nature medicine 24 (6), 724-730, 2018
|Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels|
JN Kochenderfer, RPT Somerville, T Lu, V Shi, A Bot, J Rossi, A Xue, ...
Journal of Clinical Oncology 35 (16), 1803, 2017
|Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines|
FO Smith, SG Downey, JA Klapper, JC Yang, RM Sherry, RE Royal, ...
Clinical Cancer Research 14 (17), 5610-5618, 2008
|Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma|
SL Goff, ME Dudley, DE Citrin, RP Somerville, JR Wunderlich, ...
Journal of Clinical Oncology 34 (20), 2389, 2016
|Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study|
SS Chandran, RPT Somerville, JC Yang, RM Sherry, CA Klebanoff, ...
The Lancet Oncology 18 (6), 792-802, 2017
|Treatment of patients with metastatic cancer using a major histocompatibility complex class II–restricted T-cell receptor targeting the cancer germline antigen MAGE-A3|
YC Lu, LL Parker, T Lu, Z Zheng, MA Toomey, DE White, X Yao, YF Li, ...
Journal of Clinical Oncology 35 (29), 3322, 2017
|Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL|
SL Goff, FO Smith, JA Klapper, R Sherry, JR Wunderlich, SM Steinberg, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (8), 840, 2010
|Adoptive cell therapy—tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors|
SA Feldman, Y Assadipour, I Kriley, SL Goff, SA Rosenberg
Seminars in oncology 42 (4), 626, 2015
|Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody|
FO Smith, SL Goff, JA Klapper, C Levy, T Allen, SA Mavroukakis, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 30 (1), 130, 2007
|Pilot trial of adoptive transfer of chimeric antigen receptor transduced T cells targeting EGFRvIII in patients with glioblastoma|
SL Goff, RA Morgan, JC Yang, RM Sherry, PF Robbins, NP Restifo, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 42 (4), 126, 2019
|Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve|
AS Rosemurgy, EE Zervos, M Bloomston, AJ Durkin, WC Clark, S Goff
Annals of surgery 237 (6), 820, 2003
|Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion|
SL Goff, LA Johnson, MA Black, H Xu, Z Zheng, CJ Cohen, RA Morgan, ...
Cancer immunology, immunotherapy 59 (10), 1551-1560, 2010
|Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers|
MR Parkhurst, PF Robbins, E Tran, TD Prickett, JJ Gartner, L Jia, G Ivey, ...
Cancer discovery 9 (8), 1022-1035, 2019
|Characterization of an immunogenic mutation in a patient with metastatic triple-negative breast cancer|
Y Assadipour, N Zacharakis, JS Crystal, TD Prickett, JJ Gartner, ...
Clinical Cancer Research 23 (15), 4347-4353, 2017
|Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma|
M Winner, SL Goff, JA Chabot
Seminars in oncology 42 (1), 86-97, 2015
|Metastasectomy following immunotherapy with adoptive cell transfer for patients with advanced melanoma|
ND Klemen, PL Feingold, SL Goff, MS Hughes, US Kammula, JC Yang, ...
Annals of surgical oncology 24 (1), 135-141, 2017
|No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma|
SL Goff, PF Robbins, M El-Gamil, SA Rosenberg
Journal of immunotherapy (Hagerstown, Md.: 1997) 32 (8), 884, 2009